Company Filing History:
Years Active: 2024
Title: Ulrike Baschant: Innovator in Sclerosing Disease Treatment
Introduction
Ulrike Baschant is a prominent inventor based in Dresden, Germany. She has made significant contributions to the field of medical science, particularly in the diagnosis and treatment of sclerosing diseases. Her innovative work has led to the development of a unique protein that holds promise for patients suffering from these conditions.
Latest Patents
Ulrike Baschant holds a patent for the "Use of the extracellular domain of transferrin receptor 2 for the diagnosis and treatment of primary or secondary sclerosing diseases." This invention relates to a protein that can be utilized in diagnosing and treating primary or secondary sclerosing diseases. It includes a fusion protein, nucleotide sequence, vector, and a pharmaceutical composition aimed at improving patient outcomes.
Career Highlights
Ulrike is currently associated with Kymab Limited, where she continues her research and development efforts. Her work is characterized by a commitment to advancing medical science and improving therapeutic options for patients.
Collaborations
Ulrike collaborates with notable colleagues, including Martina Rauner and Lorenz C Hofbauer. These partnerships enhance her research capabilities and contribute to the innovative environment at Kymab Limited.
Conclusion
Ulrike Baschant's contributions to the field of sclerosing disease treatment exemplify her dedication to medical innovation. Her patent and ongoing work at Kymab Limited highlight her role as a key figure in advancing healthcare solutions.